Mar 22, 2024
Congratulations to the trainees in the Bonami lab for their recently accepted manuscripts and invited talks relating to their work in beta cell regulation and type 1 diabetes.
Accepted Manuscripts:
- Bass, L.E.* and Bonami, R.H. “Factors governing B cell recognition of autoantigen and function in type 1 diabetes”. Antibodies, 2024. In press [*Graduate Student]
- Alleva, D., Delpero,A., Sathiyaseelan, T., Murikipudi, S., Lancaster, T., Atkinson, M., Wasserfall, C., Yu, L., Ragupathy, R., Bonami, R.H., and Zion, T. An antigen-specific immunotherapeutic, AKS-107, deletes insulin-specific B cells and prevents murine autoimmune diabetes. Frontiers in Immunology, 2024. In press.
Invited Talks:
- Bass, L.E.*, Taylor, T.C.**, Forchetti, M.V., Scaglione, S.R. †, Skellett, A., Mahajan, A.**, Moore, D.J., Smith, S.A., and Bonami, R.H. The complex role of somatic hypermutation in supporting insulin recognition by B lymphocytes in at-risk type 1 diabetes participants. American Association of Immunologists (AAI) annual meeting, 2024. Chicago, IL. [*Graduate Student, *Undergraduate Student, †Medical Student, Selected for one of sixteen Trainee Talks in AAI Major Symposia and received AAI Travel Award]
- McNitt, D.H.*, Williams, J.M., Santitoro, J.G.**, Kim, J. †, Thomas, J.W., and Bonami, R.H. CD4-driven loss of the key germinal center protein, BCL6, prevents type 1 diabetes development. American Association of Immunologists (AAI) annual meeting, 2024. Chicago, IL. [*Postdoctoral Fellow, **Medical Student, †Undergraduate Student, Received AAI Travel Award]
Congratulations also to Dr. Eli Steigelfest for his recent manuscript acceptance the American Journal of Hematology on vexas syndrome.